Skip to main content
Premium Trial:

Request an Annual Quote

Penn, Georgia Get $14.6M for Pathogen Database

NEW YORK (GenomeWeb News) – The University of Pennsylvania and the University of Georgia have won a $14.6 million grant from the National Institute of Allergy and Infectious Diseases to expand a pathogen genomic database that serves as a resource for scientists studying infectious diseases, Penn said today.

The Eukaryotic Pathogen Genome Database Resource (EuPathDB) is an open database that enables researchers to study genes, genomes, isolates, and other attributes of pathogens that affect humans. Disease researchers use the resource to identify potential vaccine antigens and drug targets in efforts to develop new diagnostics and therapeutics.

The most recent EUPathDB supports a total of 27 species, and provides bioinformatics for researchers focused on biodefense and emerging and re-emerging pathogens.

"It has been remarkable to witness the rapid growth of biomedical research in recent years, fueled by the genomic revolution … and it is particularly gratifying to see the impact of bioinformatics tools such as EuPathDB," David Roos, a professor of biology at Penn and director of the project, said in a statement.

"By integrating diverse sources of information -- all the genes in the genome, all the proteins in the cell, all patient responses in a population -- these databases offer great promise for improved human health," he added.

The database targets pathogens that threaten public water supplies, such as Cryposporidium, Giardia, and Toxoplasma, and others. It also may be used to study Trichomonas, the congenital pathogen Toxoplasma gondii, and the pathogens responsible for African sleeping sickness, Chagas disease, and others.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.